How Next-Generation Sequencing Differentiates Multiple Genetic Rickets Variants

Rickets is a condition marked by impaired bone mineralization, leading to bone pain, skeletal deformities and growth delays. While nutritional vitamin D deficiency is the most common cause, a range of inherited forms—collectively called genetic or hereditary rickets syndromes—require specialized testing to pinpoint the exact gene defect. Next-generation sequencing (NGS) has transformed this process, enabling simultaneous analysis of multiple genes to accurately distinguish between variants. Below, we explain how NGS works, why a dedicated genetic testing panel for hereditary rickets syndromes matters, and what to expect if you or your child undergo testing.

Understanding Next-Generation Sequencing

Next-generation sequencing refers to a family of modern technologies that read millions of DNA fragments at once. Instead of testing one gene at a time, NGS lets laboratories examine dozens—or even hundreds—of genes in parallel:

• High‐throughput: Millions of DNA strands are read in a single run.
• Broad coverage: Exons (coding regions), select introns, and regulatory areas can be included.
• Sensitive detection: Single‐nucleotide changes (SNVs), small insertions/deletions (indels) and copy‐number variations (CNVs) can all be identified.
• Faster turnaround: Results often return in 2–6 weeks, compared to months for traditional methods.

Why a Genetic Testing Panel for Hereditary Rickets Syndromes Is Key

Not all rickets share the same genetic cause or treatment plan. A well-designed genetic testing panel for hereditary rickets syndromes targets the most common and actionable genes:

• Vitamin D–dependent rickets type I (VDDR-I): CYP27B1
• Vitamin D–dependent rickets type II (VDDR-II): VDR
• X-linked hypophosphatemic rickets (XLH): PHEX
• Autosomal dominant hypophosphatemic rickets (ADHR): FGF23
• Autosomal recessive hypophosphatemic rickets (ARHR): DMP1, ENPP1
• Hereditary hypophosphatemic rickets with hypercalciuria (HHRH): SLC34A3

By including these genes—and others newly discovered—clinicians can:

• Pinpoint the exact molecular defect.
• Differentiate between forms that look similar clinically.
• Tailor treatment (e.g., high‐dose calcitriol vs. phosphate supplements vs. burosumab).
• Provide accurate genetic counseling about inheritance patterns and family risk.

The NGS Workflow: From Blood Draw to Variant Report

1. Sample Collection
   – Blood or saliva sample is sent to a molecular genetics laboratory.
2. DNA Extraction & Quantification
   – High‐quality genomic DNA is isolated and measured for concentration.
3. Library Preparation
   – DNA is fragmented; gene‐specific probes “capture” target regions.
4. Sequencing Run
   – Captured fragments are sequenced in parallel on an NGS instrument.
5. Bioinformatics Analysis
   – Raw data are aligned to a reference genome.
   – Variants (SNVs, indels, CNVs) are called and annotated.
6. Variant Interpretation
   – Each variant is classified (pathogenic, likely pathogenic, variant of uncertain significance) using ACMG guidelines.
   – Clinical context (biochemical tests, family history) refines interpretation.
7. Reporting & Counseling
   – A comprehensive report lists detected variants, clinical significance, inheritance risk and management recommendations.
   – Genetic counseling helps the patient or family understand implications.

Benefits of NGS in Genetic Rickets Diagnosis

• Comprehensive: All relevant genes are tested in one assay.
• Cost‐effective: Running one panel is less expensive than sequential single‐gene tests.
• Accurate: High coverage and depth reduce the chances of missing mutations.
• Timely: Faster results allow earlier intervention.
• Actionable: Results guide personalized treatment, from active vitamin D analogs to anti‐FGF23 therapy.

Limitations and Considerations

• Variants of Uncertain Significance (VUS)
  – Some genetic changes lack clear clinical interpretation. Functional tests or family studies may be needed.
• Incidental Findings
  – Rarely, unrelated disease-associated variants may be detected. Labs follow guidelines on reporting these.
• Incomplete Coverage
  – Very large deletions, deep intronic variants or novel genes may escape detection unless specifically targeted.
• Cost and Access
  – Insurance coverage varies; out-of-pocket costs can be significant. Discuss access and assistance programs with your provider.
• Ethical and Emotional Impact
  – Learning about hereditary risk can cause stress. Genetic counseling before and after testing is crucial.

When to Consider Genetic Testing

Genetic testing should be discussed with your doctor if any of the following apply:

• Early‐onset rickets symptoms (before age 2) despite adequate nutrition.
• Persistent low blood phosphate (hypophosphatemia) with normal vitamin D levels.
• Family history of rickets or unexplained bone deformities.
• Resistance to standard vitamin D therapy (suggesting VDDR-II).
• Unusual biochemical patterns:
  • High alkaline phosphatase (ALP)
  • Elevated parathyroid hormone (PTH) in the face of low calcium (in VDDR-I)

If you’re unsure whether your symptoms fit these descriptions, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Treatment Decisions Guided by Genetic Results

Accurate molecular diagnosis influences therapy:

• VDDR-I (CYP27B1 mutations): Active vitamin D (calcitriol or alfacalcidol).
• VDDR-II (VDR mutations): High‐dose calcitriol plus calcium, often with limited success.
• XLH (PHEX mutations): Phosphate supplements, active vitamin D analogs, or burosumab (anti-FGF23 antibody).
• ADHR/ARHR (FGF23, DMP1, ENPP1): Similar to XLH, with tailored dosing.
• HHRH (SLC34A3 mutations): High‐phosphate diet, phosphate supplements; avoid active vitamin D analog overdose.

Next Steps: Talking to Your Healthcare Team

Genetic testing is a multi-step process that benefits from close collaboration between endocrinologists, nephrologists, geneticists and genetic counselors. If testing confirms a hereditary form of rickets, ongoing follow-up will include:

• Growth and developmental monitoring.
• Regular lab assessments (phosphate, calcium, 25-OH vitamin D, ALP, PTH).
• Bone imaging to track correction of deformities.
• Family screening when indicated.

Always discuss any test findings or new symptoms with a qualified healthcare professional. If you experience severe bone pain, respiratory distress or other worrying signs, speak to a doctor right away.

---

Next-generation sequencing has revolutionized the diagnosis of hereditary rickets syndromes, offering clarity where traditional approaches often fell short. By using a focused genetic testing panel for hereditary rickets syndromes, families gain faster answers, more personalized care and informed decision-making for the future. For any new or worsening symptoms, remember to talk with your doctor—and consider a free, online symptom check, using the doctor approved Ubie Symptom Checker—to guide your next steps.